Co-Relation Between Glycated Hemoglobin (HbA1c) and Dyslipidemia in Type II Diabetics Presenting in a Tertiary Care Hospital in Pakistan
Abstract
Diabetes is a global disease that is affecting both developing and developed countries. According to a WHO
survey (1994-1998), the overall prevalence of diabetes Mellitus is 11.47% in Pakistan. Based on a study done in Pakistan
in 2015, the prevalence of dyslipidemia among people with diabetes was 95%. Both HbA1c and dyslipidemia lead to an
increased risk for cardiovascular diseases. This study aims to identify the atherosclerotic disease risk factors among the
Pakistani population to decrease morbidity and mortality. To determine the frequency of dyslipidemia among Type 2
Diabetic patients and compare dyslipidemia among Type 2 Diabetic patients with/without elevated Glycated hemoglobin
(HbA1c).
A descriptive, cross-sectional study was performed at Internal Medicine Department, Pakistan Institute of
Medical Sciences, Islamabad, Pakistan, for Six months (Feb 02, 2020, till Jul 01, 2020). HbA1c levels, serum lipid profile,
random and fasting blood sugar levels were tested. Non-probability consecutive sampling was done, and 100 patients were
registered.
Out of 100 patients, 47 were males and 53 females with a mean age of 47.85 ± 8.61. Sixty-nine diabetic patients
with elevated HbA1c showed a positive relationship with total cholesterol and LDL-C level (p<0.05). In addition, patients
with HbA1c higher than 7% showed a high risk and borderline dyslipidemia.
Elevated HbA1c, apart from being a glycemic index, is a good predictor of dyslipidemia. Therefore, patients
with borderline or desirable lipid profile values with high HbA1c levels should start statin therapy or lifestyle modification
to prevent cardiovascular diseases.
How to Cite This Article
Rehman HU. Co-Relation Between Glycated Hemoglobin (HbA1c) and Dyslipidemia in Type II Diabetics Presenting in a Tertiary Care Hospital in Pakistan. J Pak Soc Intern Med. 2021;2(3):236–240. doi:10.70302/jpsim.v2i3.2154
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Sarfraz M, Sajid S, Ashraf MA. Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population. Saudi J Biol Sci. 2016;23(6):761-6.
- Alyasiri HM, Sadoon AA, Mohan K. Relationship between hba1c and hyperlipidaemia in patients with diabetes mellitus. Thi-Qar Med J. 2012;6(1):8-17.
- Meenu J, Jadeja Jayendrasinh M, Neeta M. Correlation between HbA1c values and lipid profile in type 2 diabetes mellitus. TC (mg/dl). Int J Basic Appl Physiol. 2013;147(35.40).
- Yan Z, Liu Y, Huang H. Association of glycosylated hemoglobin level with lipid ratio and individual lipids in type 2 diabetic patients. Asian Pac J Trop Med. 2012;5(6):469-71.
- Karar T, Alhammad RI, Fattah MA, Alanazi A, Qureshi S. Relation between glycosylated hemoglobin and lipid and thyroid hormone among patients with type 2 diabetes mellitus at King Abdulaziz Medical City, Riyadh. J Nat Sc Biol Med. 2015;6(Suppl 1): S75.
- Hussain A, Ali I, Ijaz M, Rahim A. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia. Ther Adv Endocrinol Metab. 2017;8(4):51-7.
- Prabhavathi K, Kunikullaya K, Goturu J. Glycosylated haemoglobin (HbA1C)-A marker of circulating lipids in type 2 diabetic patients. J Clin Diagn. 2014;8(2):20.
- Ashraf H, Boroumand MA, Amirzadegan A, Talesh SA, Davoodi G. Hemoglobin A1C in non-diabetic patients: an independent predictor of coronary artery disease and its severity. Diabetes Res Clin Prac. 2013;102(3):225-32.
- Nathan DM, DCCT/Edic Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes care. 2014;37(1):9-16.
- Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation. 2002;106(3):388-91
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.